{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:43:34Z","timestamp":1792511014446,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","award":["309854"],"award-info":[{"award-number":["309854"]}],"id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"DOI":"10.1007\/s10689-026-00564-1","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:02:00Z","timestamp":1777366920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trends in breast reconstruction for BRCA1\/2, PALB2 and other high penetrance germline pathogenic variant carriers undergoing risk reducing mastectomy"],"prefix":"10.1007","volume":"25","author":[{"given":"Amel","family":"Melanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marya","family":"Alsuhaibani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Viezel-Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tassos","family":"Dionisopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Basik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Francois","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karyne","family":"Martel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ipshita","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarkis","family":"Meterissian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Vorstenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Foulkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"5645","key":"564_CR1","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1126\/science.1088759","volume":"302","author":"MC King","year":"2003","unstructured":"King MC et al (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302(5645):643\u2013646","journal-title":"Science"},{"issue":"5","key":"564_CR2","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"issue":"6","key":"564_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1056\/NEJMoa1400382","volume":"371","author":"AC Antoniou","year":"2014","unstructured":"Antoniou AC et al (2014) Breast-cancer risk in families with mutations in PALB2. N Engl J Med 371(6):497\u2013506","journal-title":"N Engl J Med"},{"issue":"4","key":"564_CR4","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.amjsurg.2016.06.010","volume":"212","author":"KK Ludwig","year":"2016","unstructured":"Ludwig KK et al (2016) Risk reduction and survival benefit of prophylactic surgery in BRCA mutation carriers, a systematic review. Am J Surg 212(4):660\u2013669","journal-title":"Am J Surg"},{"issue":"1","key":"564_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41416-019-0446-1","volume":"121","author":"K Metcalfe","year":"2019","unstructured":"Metcalfe K et al (2019) International trends in the uptake of cancer risk reduction strategies in women with a BRCA1 or BRCA2 mutation. Br J Cancer 121(1):15\u201321","journal-title":"Br J Cancer"},{"key":"564_CR6","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jss.2019.02.002","volume":"239","author":"H Chen","year":"2019","unstructured":"Chen H et al (2019) Growing Trends of Contralateral Prophylactic Mastectomy and Reconstruction in Young Breast Cancer. J Surg Res 239:224\u2013232","journal-title":"J Surg Res"},{"key":"564_CR7","doi-asserted-by":"publisher","first-page":"608787","DOI":"10.3389\/fgwh.2021.608787","volume":"2","author":"MJ Boivin","year":"2021","unstructured":"Boivin MJ et al (2021) Health-Related Quality of Life: Longitudinal Analysis From the Time of Breast Biopsy Into the Post-treatment Period. Front Glob Womens Health 2:608787","journal-title":"Front Glob Womens Health"},{"issue":"12","key":"564_CR8","doi-asserted-by":"publisher","first-page":"3817","DOI":"10.1245\/s10434-013-3040-4","volume":"20","author":"J Semple","year":"2013","unstructured":"Semple J et al (2013) International rates of breast reconstruction after prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers. Ann Surg Oncol 20(12):3817\u20133822","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"564_CR9","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1097\/01.PRS.0000131877.52740.0E","volume":"114","author":"KA Metcalfe","year":"2004","unstructured":"Metcalfe KA, Semple JL, Narod SA (2004) Satisfaction with breast reconstruction in women with bilateral prophylactic mastectomy: a descriptive study. Plast Reconstr Surg 114(2):360\u2013366","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"564_CR10","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1097\/SAP.0000000000000242","volume":"76","author":"SK Ng","year":"2016","unstructured":"Ng SK et al (2016) Breast Reconstruction Post Mastectomy: Patient Satisfaction and Decision Making. Ann Plast Surg 76(6):640\u2013644","journal-title":"Ann Plast Surg"},{"issue":"1","key":"564_CR11","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1007\/s12282-019-00995-y","volume":"27","author":"N Nagura","year":"2020","unstructured":"Nagura N et al (2020) Breast reconstruction after risk-reducing mastectomy in BRCA mutation carriers. Breast Cancer 27(1):70\u201376","journal-title":"Breast Cancer"},{"issue":"5S Advances in","key":"564_CR12","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1097\/PRS.0000000000003941","volume":"140","author":"H Panchal","year":"2017","unstructured":"Panchal H, Matros E (2017) Current Trends in Postmastectomy Breast Reconstruction. Plast Reconstr Surg 140(5S Advances in Breast Reconstruction):7S\u201313S","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"564_CR13","doi-asserted-by":"publisher","first-page":"e4277","DOI":"10.1097\/GOX.0000000000004277","volume":"10","author":"VJ Hu","year":"2022","unstructured":"Hu VJ et al (2022) Current Trends in Breast Reconstruction following Bilateral Prophylactic Mastectomy. Plast Reconstr Surg Glob Open 10(4):e4277","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"564_CR14","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA et al (2019) The REDCap consortium: Building an international community of software platform partners. J Biomed Inf 95:103208","journal-title":"J Biomed Inf"},{"issue":"1","key":"564_CR15","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1038\/s41598-021-82654-x","volume":"11","author":"NN Basu","year":"2021","unstructured":"Basu NN et al (2021) The Angelina Jolie effect: Contralateral risk-reducing mastectomy trends in patients at increased risk of breast cancer. Sci Rep 11(1):2847","journal-title":"Sci Rep"},{"issue":"2","key":"564_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10549-018-4824-9","volume":"171","author":"A Liede","year":"2018","unstructured":"Liede A et al (2018) Risk-reducing mastectomy rates in the US: a closer examination of the Angelina Jolie effect. Breast Cancer Res Treat 171(2):435\u2013442","journal-title":"Breast Cancer Res Treat"},{"key":"564_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.breast.2019.03.011","volume":"46","author":"AD Baildam","year":"2019","unstructured":"Baildam AD (2019) Current knowledge of risk reducing mastectomy: Indications, techniques, results, benefits, harms. Breast 46:48\u201351","journal-title":"Breast"},{"issue":"4","key":"564_CR18","doi-asserted-by":"publisher","first-page":"e0281601","DOI":"10.1371\/journal.pone.0281601","volume":"18","author":"A Aslam","year":"2023","unstructured":"Aslam A et al (2023) Bilateral risk-reducing mastectomy and reconstruction-A 12-year review of methodological trends and outcomes at a tertiary referral centre. PLoS ONE 18(4):e0281601","journal-title":"PLoS ONE"},{"issue":"3","key":"564_CR19","doi-asserted-by":"publisher","first-page":"320e","DOI":"10.1097\/PRS.0b013e31827cf576","volume":"131","author":"Y Cemal","year":"2013","unstructured":"Cemal Y et al (2013) A paradigm shift in U.S. breast reconstruction: Part 2. The influence of changing mastectomy patterns on reconstructive rate and method. Plast Reconstr Surg 131(3):320e\u2013326e","journal-title":"Plast Reconstr Surg"},{"issue":"4","key":"564_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/01.NCC.0000281733.40856.c4","volume":"30","author":"SJ Rolnick","year":"2007","unstructured":"Rolnick SJ et al (2007) What women wish they knew before prophylactic mastectomy. Cancer Nurs 30(4):285\u2013291","journal-title":"Cancer Nurs"},{"issue":"4","key":"564_CR21","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/jayao.2019.0002","volume":"8","author":"SM Rosenberg","year":"2019","unstructured":"Rosenberg SM et al (2019) Factors Affecting Surgical Decisions in Newly Diagnosed Young Women with Early-Stage Breast Cancer. J Adolesc Young Adult Oncol 8(4):463\u2013468","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"4","key":"564_CR22","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1097\/PRS.0000000000006627","volume":"145","author":"AO Momoh","year":"2020","unstructured":"Momoh AO et al (2020) Postmastectomy Breast Reconstruction: Exploring Plastic Surgeon Practice Patterns and Perspectives. Plast Reconstr Surg 145(4):865\u2013876","journal-title":"Plast Reconstr Surg"},{"issue":"9","key":"564_CR23","doi-asserted-by":"publisher","first-page":"e507","DOI":"10.1097\/GOX.0000000000000484","volume":"3","author":"DR Leff","year":"2015","unstructured":"Leff DR et al (2015) Trends in Immediate Postmastectomy Breast Reconstruction in the United Kingdom. Plast Reconstr Surg Glob Open 3(9):e507","journal-title":"Plast Reconstr Surg Glob Open"},{"issue":"2","key":"564_CR24","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00266-021-02664-y","volume":"46","author":"R ElAbd","year":"2022","unstructured":"ElAbd R et al (2022) Autologous Versus Alloplastic Reconstruction for Patients with Obesity: A Systematic Review and Meta-analysis. Aesthetic Plast Surg 46(2):597\u2013609","journal-title":"Aesthetic Plast Surg"},{"issue":"10","key":"564_CR25","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1001\/jamasurg.2018.1677","volume":"153","author":"KB Santosa","year":"2018","unstructured":"Santosa KB et al (2018) Long-term Patient-Reported Outcomes in Postmastectomy Breast Reconstruction. JAMA Surg 153(10):891\u2013899","journal-title":"JAMA Surg"},{"issue":"1","key":"564_CR26","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/SLA.0000000000002033","volume":"267","author":"EG Wilkins","year":"2018","unstructured":"Wilkins EG et al (2018) Complications in Postmastectomy Breast Reconstruction: One-year Outcomes of the Mastectomy Reconstruction Outcomes Consortium (MROC) Study. Ann Surg 267(1):164\u2013170","journal-title":"Ann Surg"},{"issue":"4","key":"564_CR27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1097\/01.prs.0000232362.82402.e8","volume":"118","author":"PG Cordeiro","year":"2006","unstructured":"Cordeiro PG, McCarthy CM (2006) A single surgeon\u2019s 12-year experience with tissue expander\/implant breast reconstruction: part I. A prospective analysis of early complications. Plast Reconstr Surg 118(4):825\u2013831","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"564_CR28","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/PRS.0b013e31817151c4","volume":"121","author":"CM McCarthy","year":"2008","unstructured":"McCarthy CM et al (2008) Predicting complications following expander\/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121(6):1886\u20131892","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"564_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/SAP.0000000000000109","volume":"75","author":"F Lovecchio","year":"2015","unstructured":"Lovecchio F et al (2015) Risk Factors for Complications Differ Between Stages of Tissue-Expander Breast Reconstruction. Ann Plast Surg 75(3):275\u2013280","journal-title":"Ann Plast Surg"},{"issue":"2","key":"564_CR30","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s00266-023-03258-6","volume":"47","author":"H Mortada","year":"2023","unstructured":"Mortada H et al (2023) The Impact of Diabetes Mellitus on Breast Reconstruction Outcomes and Complications: A Systematic Literature Review and Meta-analysis. Aesthetic Plast Surg 47(2):570\u2013583","journal-title":"Aesthetic Plast Surg"},{"issue":"2","key":"564_CR31","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1245\/s10434-024-16484-2","volume":"32","author":"P Singh","year":"2025","unstructured":"Singh P et al (2025) Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks. Ann Surg Oncol 32(2):899\u2013911","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"564_CR32","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1245\/s10434-023-14418-y","volume":"31","author":"C Apostolova","year":"2024","unstructured":"Apostolova C et al (2024) Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy. Ann Surg Oncol 31(1):356\u2013364","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"564_CR33","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.3390\/jcm11113079","volume":"11","author":"A Weinzierl","year":"2022","unstructured":"Weinzierl A et al. (2022) Implant-based breast reconstruction after mastectomy, from the subpectoral to the prepectoral approach: an evidence-based change of mind? J Clin Med, 11(11):3079","journal-title":"J Clin Med"},{"issue":"4","key":"564_CR34","doi-asserted-by":"publisher","first-page":"686e","DOI":"10.1097\/PRS.0000000000006654","volume":"145","author":"T Safran","year":"2020","unstructured":"Safran T et al (2020) Direct-to-Implant, Prepectoral Breast Reconstruction: A Single-Surgeon Experience with 201 Consecutive Patients. Plast Reconstr Surg 145(4):686e\u2013696e","journal-title":"Plast Reconstr Surg"},{"issue":"13","key":"564_CR35","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1245\/s10434-021-10085-z","volume":"28","author":"CA King","year":"2021","unstructured":"King CA et al (2021) A Critical Appraisal of Late Complications of Prepectoral versus Subpectoral Breast Reconstruction Following Nipple-Sparing Mastectomy. Ann Surg Oncol 28(13):9150\u20139158","journal-title":"Ann Surg Oncol"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00564-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10689-026-00564-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-026-00564-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:02:02Z","timestamp":1777366922000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10689-026-00564-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["564"],"URL":"https:\/\/doi.org\/10.1007\/s10689-026-00564-1","relation":{},"ISSN":["1573-7292"],"issn-type":[{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jean-Francois Boileau reports honoraria from Roche, Novartis, Genomic Health, Pfizer, Allergan, and Merck; personal fees from Roche, Genomic Health, NanoString Technologies, Pfizer, Eli Lilly, Novartis, and Merck; and travel support from Roche, GlaxoSmithKline, Novartis, Pfizer, and Lifecell outside the submitted work. Ipshita Prakash reports honoraria from Roche outside of the submitted work. Stephanie Wong reports honoraria from AstraZeneca, Novartis and Merck, outside of the submitted work. The remaining authors have no conflict of interest to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained by the CIUSSS (integrated university health and social service centres) West Central Montreal Research Ethics Board associated with the Jewish General Hospital. Given the de-identified, retrospective nature of the data, consent from individual participants was waived by West Central Montreal Research Ethics Board associated with the Jewish General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"48"}}